9999999997-18-003881.txt : 20180327 9999999997-18-003881.hdr.sgml : 20180327 20180327163652 ACCESSION NUMBER: 9999999997-18-003881 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180327 DATE AS OF CHANGE: 20180327 ACTION DATE: 20180327 RECEIVED DATE: 20180327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 18715828 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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